Learn more about our Global Affairs work.
AdvaMed, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring…
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply…
AdvaMed President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India:
The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely…
In times of crisis, the medtech industry stands as a pillar of strength, providing innovative solutions to address immediate needs and foster resilience. Discover a few NGOs that AdvaMed members…
As the International Civil Aviation Organization (ICAO) Dangerous Goods Panel meets this week, AdvaMed, the Medtech Association, led a group of 24 global medtech organizations in expressing concerns about the…
The 17th edition of EY’s Pulse of the Industry report offers a chance to take stock of the US and European medtech industry’s performance in 2023.
AdvaMed is collaborating with the U.S. and Ukrainian governments to facilitate donations of urgently needed medical supplies to Ukraine.
The United States International Trade Commission (USITC) released its highly anticipated report,“COVID-19 Diagnostics and Therapeutics, Supply, Demand, and TRIPS Agreement Flexibilities” on October 17. Evidence presented in the 496-page report…